Skip to main content
. 2018 Nov 21;7(23):e009975. doi: 10.1161/JAHA.118.009975

Table 4.

EAT and Chamber Geometry

Author Modality Subgroup LV‐EDD LA Size (Diameter/Volume) LVEDMI LV‐EDVI LV‐ESVI LVRI Comment
Bukkam8 CT 0.42a , b On multivariable regression adjusted for traditional cardiovascular risk factors, CACS and BMI, EAT was not a significant predictor of LV mass in obese patients, but only in nonobese patients (β=0.23, P<0.001)
Cavalcante9 Echocardiography 0.41a Measure not included in multivariate analysis
Al Chekakie7 CT and echocardiography 0.25/0.24
Doesch11 MRI EF <50% (n=44)
EF >50% (n=114)
Combined (n=158)
0.076
0.011
0.272a
0.336a
0.305a
0.019
0.201a
0.043
0.16a
0.089
0.056
0.262a
0.137
0.202
0.344a
On multivariable regression including LVEF, BMI, NYHA classes I and III, atrial fibrillation, LV‐EDVI, LV‐ESVI, LV‐EFF, LVRI, and LGE%, best correlates to indexed EAT were LVEF, BMI, LV‐ESVI (HR, 0.48; P<0.01), and LV‐EDD (HR, −0.238; P=0.01). In subgroup analysis by EF <50% or >50%, full model not described; however, no association with LVEDMI in LVEF >50% but association seen in LVEF >50% (HR, 0.105; P=0.01)
Doesch12 MRI Control (n=48)
DCM (n=112)
0.01
0.22a
0.346a
0.417a
0.007
0.251a
0.0001
0.239a
0.204
0.116
Increased EAT mass with increasing LVEDMI in DCM, but less values than healthy control group. Greater mass seen in DCM with hypertrophy vs nonhypertrophy (31.7±5.6 vs 24.4±7.1 g/m2; P=0.01). On multivariable regression only, LVEDMI independently correlated with indexed EAT, as was seen in healthy controls (adjusted for age and BMI [value not reported]).
Doesch10 MRI Control
CHF
NR
0.42a
0.36a
0.59a
Increased EAT mass in CHF with increasing LVEDMI; however, higher levels of EAT in controls compared with CHF (34±4 vs 22±5 g/m2; P<0.01). On multivariate regression adjusted for LVEF, LV‐EDD, RVEF, and LVEDMI, only LVEDMI independently associated with indexed EAT (P=0.0001)
Fox17 MRI Women
Men
0.28a
0.37a
0.35a , c
0.19a , c
0.2a , c
0.07c
On multivariable regression adjusted for age, height, smoking, alcohol, menopause, hormone replacement therapy, blood pressure, hypertension therapy, and weight, only in women, LVM (adjusted regression coefficient, 1.66; P=0.01), and in men, LA diameter (adjusted regression coefficient, 0.8; P=0.002) were independent predictors of pericardial fat volume
Hachiya18 Echocardiography 0.28a Measure not included in multivariate analysis
Konishi20 Echocardiography 0.32a 0.23a Measure not included in multivariate analysis
Liu22 Echocardiography Women
Men
0.3a
0.11
0.24a , c
0.21a , c
On multivariable regression adjusted for age, height, smoking, alcohol, blood pressure, eGFR, hemoglobin, total physical activity score, medications, VAT, and weight, only in women, LVM (adjusted regression coefficient, 4.1±1.8; P=0.03) and LA diameter (adjusted regression coefficient, 0.4±0.2; P=0.03) were independent predictors of pericardial fat volume
Ng24 Echocardiography −0.09 0.08
Ruberg3 MRI Not
Vanni25, d MRI Cases 0.46a , e Inversely correlated with EF
No other analysis specified
Yamashita28, d CT 0.25a

Values are mean±SD or r value correlation coefficients, unless otherwise stated. BMI indicates body mass index; CACS, coronary artery calcium score; CHF, congestive heart failure; CT, computed tomography; DCM, dilated cardiomyopathy; EAT, epicardial adipose tissue; EF, ejection fraction; eGFR, estimated glomerular filtration rate; HR, hazard ratio; LA, left atrial; LGE%, percentage of late gadolinium enhancement; LV, left ventricular; LV‐EDVI, LV end‐diastolic volume index; LV‐EDD, LV end‐diastolic diameter; LVEF, LV ejection fraction; LVEDMI, LV end‐diastolic mass index; LV‐EDVI, LV end‐diastolic volume index; LV‐ESVI, LV end‐systolic volume index; LVRI, LV remodeling index; MRI, magnetic resonance imaging; NR, not reported; NYHA, New York Heart Association; RVEF, right ventricular EF; VAT, visceral adipose tissue.

a

P < 0.05.

b

Value is for LV mass on CT, nonindexed and time in cardiac cycle not specified.

c

Represents a nonindexed measure.

d

Study is a conference abstract.

e

Value is for end‐systolic LV diameter.